Task: Please answer the following question about the molecule with SMILES CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1.
Description: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Result: Approved
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1
CCC[C@@H]1CC(=O)N([C@@H](CC)C(N)=O)C1
(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.